\-\ Texto\\:\\ \ \(0\)\
\-\ pe\\:\\ \\ abdominal\\ exam\\ revealed\\ an\\ enlarged\\ liver\\ and\\ generalized\\ abdominal\\ tenderness\\.\ \(0\)\
\-\ labs\\:\\ \\ alpha\\-fetoprotein\\ \\(afp\\)\\ \\>363000\\,\\ ast\\ 819\\ and\\ alt\\ 129\\,\\ ldh\\ 1675\ \(0\)\
\-\ the\\ patient\\ is\\ currently\\ undergoing\\ chemotherapy\\ to\\ attempt\\ to\\ shrink\\ the\\ tumor\\ size\\.\\ \\ if\\ that\\ is\\ successful\\,\\ surgical\\ resection\\ will\\ be\\ considered\\.\ \(0\)\
\-\ \\â\\€\\¢\\ axial\\ ct\\ images\\ of\\ the\\ abdomen\\ with\\ iv\\ contrast\\ reveal\\:\ \(0\)\
\-\ enlarged\\ liver\ \(2\)\
\-\ hepatic\\ parenchyma\\ almost\\ entirely\\ replaced\\ by\\ heterogeneous\\ low\\ attenuation\\ masses\ \(0\)\
\-\ no\\ calcifications\ \(7\)\
\-\ scattered\\ areas\\ of\\ necrosis\ \(0\)\
\-\ hepatoblastoma\ \(1\)\
\-\ \\â\\€\\¢\\ hepatoblastoma\ \(0\)\
\-\ \\â\\€\\¢\\ infantile\\ hemangioendothelioma\ \(0\)\
\-\ \\â\\€\\¢\\ metastatic\\ neuroblastoma\ \(0\)\
\-\ one\\ year\\ old\\ boy\\ with\\ a\\ 10\\ day\\ history\\ of\\ fevers\\,\\ lethargy\\,\\ and\\ abdominal\\ pain\\.\\ \\ no\\ history\\ of\\ prematurity\\ or\\ gestational\\ or\\ delivery\\ complications\\.\\ \\ the\\ patient\\ was\\ \\"healthy\\"\\ until\\ 10\\ days\\ ago\\.\ \(0\)\
\-\ \\â\\€\\¢\\ this\\ patient\\ was\\ not\\ premature\\ and\\ usually\\ hepatoblastomas\\ present\\ in\\ premature\\ infants\\.\\ \\ \ \(0\)\
\-\ \\â\\€\\¢\\ only\\ 20\\%\\ of\\ cases\\ have\\ elevated\\ liver\\ transaminases\\ along\\ with\\ an\\ elevated\\ afp\\ \\(alpha\\-feto\\-protein\\)\\.\\ \\ \ \(0\)\
\-\ \\â\\€\\¢\\ tumor\\ calcifications\\ \\ are\\ seen\\ in\\ only\\ 30\\-50\\%\\ of\\ cases\\,\\ this\\ patient\\ did\\ not\\ have\\ any\\ calcifications\\.\\ \\ \ \(0\)\
\-\ \\â\\€\\¢\\ only\\ one\\-third\\ of\\ patients\\ have\\ a\\ tumor\\ with\\ suitable\\ size\\ and\\ location\\ so\\ that\\ complete\\ excision\\ can\\ be\\ attempted\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ hepatoblastoma\\:\\ 0\\.061733965222487704\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.0594128664112185\ \(0\)\
\-\ afp\\:\\ 0\\.049859434715422604\ \(0\)\
\-\ calcifications\\:\\ 0\\.045172944378664724\ \(0\)\
\-\ premature\\:\\ 0\\.044138723607647645\ \(0\)\
\-\ liver\\:\\ 0\\.041889405367289904\ \(0\)\
\-\ 363000\\:\\ 0\\.04177970817045734\ \(0\)\
\-\ 819\\:\\ 0\\.04177970817045734\ \(0\)\
\-\ 1675\\:\\ 0\\.04177970817045734\ \(0\)\
\-\ hepatoblastomas\\:\\ 0\\.04177970817045734\ \(0\)\
\-\ alpha\\-feto\\-protein\\:\\ 0\\.04177970817045734\ \(0\)\
\-\ only\\:\\ 0\\.036531919314951686\ \(0\)\
\-\ 30\\-50\\:\\ 0\\.035209592714912835\ \(0\)\
\-\ \\-\\:\\ 0\\.034724710117694096\ \(0\)\
\-\ suitable\\:\\ 0\\.03328795713146182\ \(0\)\
\-\ shrink\\:\\ 0\\.032557385189152535\ \(0\)\
\-\ 129\\:\\ 0\\.03192453498714058\ \(0\)\
\-\ hemangioendothelioma\\:\\ 0\\.03192453498714058\ \(0\)\
\-\ transaminases\\:\\ 0\\.03192453498714058\ \(0\)\
\-\ abdominal\\:\\ 0\\.030368519973300215\ \(0\)\
\-\ alpha\\-fetoprotein\\:\\ 0\\.030002899403689564\ \(0\)\
\-\ one\\-third\\:\\ 0\\.028945347027792834\ \(0\)\
\-\ tumor\\:\\ 0\\.02832557774802101\ \(0\)\
\-\ enlarged\\:\\ 0\\.027636218676625655\ \(0\)\
\-\ elevated\\:\\ 0\\.027481671671649888\ \(0\)\
\-\ prematurity\\:\\ 0\\.027350691877929267\ \(0\)\
\-\ 10\\:\\ 0\\.027304495055420954\ \(0\)\
\-\ size\\:\\ 0\\.027155221529656604\ \(0\)\
\-\ cases\\:\\ 0\\.02698398923204865\ \(0\)\
\-\ infantile\\:\\ 0\\.026338492350450313\ \(0\)\
\-\ have\\:\\ 0\\.026309546137892298\ \(0\)\
\-\ replaced\\:\\ 0\\.026159628236787535\ \(0\)\
\-\ lethargy\\:\\ 0\\.025504887296120153\ \(0\)\
\-\ ldh\\:\\ 0\\.025354419531596076\ \(0\)\
\-\ entirely\\:\\ 0\\.024796206092466296\ \(0\)\
\-\ infants\\:\\ 0\\.023532563138656114\ \(0\)\
\-\ attempt\\:\\ 0\\.02323931477980262\ \(0\)\
\-\ attempted\\:\\ 0\\.02261832775417985\ \(0\)\
\-\ ast\\:\\ 0\\.021995882246781333\ \(0\)\
\-\ alt\\:\\ 0\\.021995882246781333\ \(0\)\
\-\ successful\\:\\ 0\\.021577433871683333\ \(0\)\
\-\ gestational\\:\\ 0\\.021577433871683333\ \(0\)\
\-\ generalized\\:\\ 0\\.02119295261664841\ \(0\)\
\-\ delivery\\:\\ 0\\.02078057642238476\ \(0\)\
\-\ neuroblastoma\\:\\ 0\\.02024750541088386\ \(0\)\
\-\ undergoing\\:\\ 0\\.01986040573783046\ \(0\)\
\-\ almost\\:\\ 0\\.01958951278124303\ \(0\)\
\-\ fevers\\:\\ 0\\.019250844705498267\ \(0\)\
\-\ \\%\\:\\ 0\\.018894038230767848\ \(0\)\
\-\ scattered\\:\\ 0\\.018858940838933747\ \(0\)\
\-\ so\\:\\ 0\\.01842779497066016\ \(0\)\
\-\ healthy\\:\\ 0\\.01825911750571844\ \(0\)\
\-\ pe\\:\\ 0\\.018193292329601537\ \(0\)\
\-\ reveal\\:\\ 0\\.018032621468579348\ \(0\)\
\-\ until\\:\\ 0\\.017786366781703943\ \(0\)\
\-\ parenchyma\\:\\ 0\\.017248192850202224\ \(0\)\
\-\ hepatic\\:\\ 0\\.016912295506189633\ \(0\)\
\-\ excision\\:\\ 0\\.016622041358129353\ \(0\)\
\-\ considered\\:\\ 0\\.016348542222486478\ \(0\)\
\-\ attenuation\\:\\ 0\\.01628256431481535\ \(0\)\
\-\ patient\\:\\ 0\\.016238709590832002\ \(0\)\
\-\ \\:\\:\\ 0\\.01607025804726064\ \(0\)\
\-\ currently\\:\\ 0\\.016048212298635345\ \(0\)\
\-\ complications\\:\\ 0\\.016048212298635345\ \(0\)\
\-\ necrosis\\:\\ 0\\.015986259305425143\ \(0\)\
\-\ ago\\:\\ 0\\.015074544174394544\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.014891920174383913\ \(0\)\
\-\ iv\\:\\ 0\\.014779265106450683\ \(0\)\
\-\ did\\:\\ 0\\.014622837161103906\ \(0\)\
\-\ 20\\:\\ 0\\.01456168358368254\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.014516330735264765\ \(0\)\
\-\ complete\\:\\ 0\\.014252966511782249\ \(0\)\
\-\ location\\:\\ 0\\.014126576715184328\ \(0\)\
\-\ labs\\:\\ 0\\.014085184866991177\ \(0\)\
\-\ that\\:\\ 0\\.01399033865932534\ \(0\)\
\-\ boy\\:\\ 0\\.013766453933298443\ \(0\)\
\-\ masses\\:\\ 0\\.013690011364910368\ \(0\)\
\-\ areas\\:\\ 0\\.01362723777841738\ \(0\)\
\-\ \\>\\:\\ 0\\.013455770211699358\ \(0\)\
\-\ along\\:\\ 0\\.01338414159648586\ \(0\)\
\-\ revealed\\:\\ 0\\.012997506587043097\ \(0\)\
\-\ day\\:\\ 0\\.012857629522999667\ \(0\)\
\-\ any\\:\\ 0\\.01275277266858907\ \(0\)\
\-\ will\\:\\ 0\\.01267052615345565\ \(0\)\
\-\ resection\\:\\ 0\\.012629932016683502\ \(0\)\
\-\ be\\:\\ 0\\.012490585055392694\ \(0\)\
\-\ days\\:\\ 0\\.012412674389440652\ \(0\)\
\-\ tenderness\\:\\ 0\\.012317120013657031\ \(0\)\
\-\ usually\\:\\ 0\\.01229823816998464\ \(0\)\
\-\ abdomen\\:\\ 0\\.011997081814671549\ \(0\)\
\-\ not\\:\\ 0\\.011704442386179483\ \(0\)\
\-\ axial\\:\\ 0\\.01155825344107996\ \(0\)\
\-\ low\\:\\ 0\\.011261459966191469\ \(0\)\
\-\ an\\:\\ 0\\.011200614827343412\ \(0\)\
\-\ history\\:\\ 0\\.011186867655991313\ \(0\)\
\-\ if\\:\\ 0\\.010989305373367942\ \(0\)\
\-\ one\\:\\ 0\\.010975030252657081\ \(0\)\
\-\ patients\\:\\ 0\\.01048139620552619\ \(0\)\
\-\ metastatic\\:\\ 0\\.010194831296758723\ \(0\)\
\-\ \\`\\`\\:\\ 0\\.009953246623847474\ \(0\)\
\-\ \\'\\'\\:\\ 0\\.009761845980958498\ \(0\)\
\-\ or\\:\\ 0\\.009493106625248413\ \(0\)\
\-\ was\\:\\ 0\\.009367559452262435\ \(0\)\
\-\ can\\:\\ 0\\.009185887926393695\ \(0\)\
\-\ present\\:\\ 0\\.009146960919107492\ \(0\)\
\-\ this\\:\\ 0\\.009110305339470456\ \(0\)\
\-\ contrast\\:\\ 0\\.009065287615203343\ \(0\)\
\-\ exam\\:\\ 0\\.00889684331729639\ \(0\)\
\-\ surgical\\:\\ 0\\.008512899385077979\ \(0\)\
\-\ no\\:\\ 0\\.008155868727050257\ \(0\)\
\-\ seen\\:\\ 0\\.008002974478993794\ \(0\)\
\-\ images\\:\\ 0\\.007769023184594096\ \(0\)\
\-\ \\,\\:\\ 0\\.0076979165549939535\ \(0\)\
\-\ \\(\\:\\ 0\\.006847030580510526\ \(0\)\
\-\ \\)\\:\\ 0\\.006763390446571612\ \(0\)\
\-\ by\\:\\ 0\\.006743463996421208\ \(0\)\
\-\ ct\\:\\ 0\\.005664946224606839\ \(0\)\
\-\ are\\:\\ 0\\.0055207292536947955\ \(0\)\
\-\ is\\:\\ 0\\.005329770411229627\ \(0\)\
\-\ pain\\:\\ 0\\.004946010272657511\ \(0\)\
\-\ year\\:\\ 0\\.0045313045937104965\ \(0\)\
\-\ and\\:\\ 0\\.004265616249578636\ \(0\)\
\-\ old\\:\\ 0\\.0041466094638021546\ \(0\)\
\-\ to\\:\\ 0\\.004048038942587547\ \(0\)\
\-\ in\\:\\ 0\\.003994286541613791\ \(0\)\
\-\ of\\:\\ 0\\.0038650550027768678\ \(0\)\
\-\ a\\:\\ 0\\.0037592398276644675\ \(0\)\
\-\ the\\:\\ 0\\.0026208395204478825\ \(0\)\
\-\ with\\:\\ 0\\.002218088646253834\ \(0\)\
\-\ \\.\\:\\ 0\\.0016824424690685437\ \(0\)\
